{"version":"1.0","type":"link","title":"Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests.","author_name":"Xing J 외","author_url":"https://prs-insight.online/author/Xing%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/125208","thumbnail_width":1200,"thumbnail_height":630}